"Profitability comes from low-cost manufacturing," says Jean-Michel Halfon, Pfizer president for emerging markets. "Low-cost solutions developed in emerging markets could be useful everywhere. We're working on it." Article
"Profitability comes from low-cost manufacturing," says Jean-Michel Halfon, Pfizer president for emerging markets. "Low-cost solutions developed in emerging markets could be useful everywhere. We're working on it." Article